{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:55:48Z","timestamp":1776318948881,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute respiratory distress syndrome (ARDS) is a major complication in hospitalized patients with coronavirus disease 2019 (COVID-19). Early identification of patients at increased risk of ARDS progression and invasive ventilation remains clinically important. This study aimed to investigate whether plasma hyaluronic acid (HA), alone or in combination with established clinical severity scores, could help identify ARDS, stratify severe disease, and assess the risk of endotracheal intubation in patients with COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center cohort study included 502 adult patients with COVID-19 admitted between September 2022 and February 2023. Plasma HA levels were measured within 24 hours after admission. Demographic characteristics, comorbidities, laboratory findings, clinical severity scores, and outcome data were collected. Receiver operating characteristic analysis, multivariable logistic regression, and nomogram construction were used to evaluate the association of HA with ARDS diagnosis, severe ARDS stratification, and intubation risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This retrospective cohort analysis of 502 COVID-19 patients (361 in the non-ARDS group and 141 in the ARDS group) identified plasma hyaluronic acid (HA) as a potential biomarker for early ARDS diagnosis, severity stratification, and intubation risk assessment. HA levels were positively correlated with disease severity, with concentrations significantly increasing alongside ARDS severity, and showed good discrimination for ARDS (AUC\u00a0=\u00a00.904; sensitivity 81.6%, specificity 87.5% at a cut-off of 103 \u03bcg\/L). HA also demonstrated excellent discrimination for severe ARDS, with an AUC of 0.953, comparable to that of the APACHE II and SOFA scores. It also showed good discrimination for endotracheal intubation risk in the overall cohort. The AUC for predicting intubation requirement reached 0.890 (sensitivity 76.6%, specificity 90.8%, NPV\u00a0=\u00a095.5% at a cut-off value of 140.1 \u03bcg\/L). Integrating HA with clinical scores further improved model performance; incorporating age, lymphocyte count, CRP, CK, APACHE II, and SOFA into the baseline model increased the AUC for predicting severe ARDS from 0.960 to 0.973 (\u0394AUC = 0.013). Furthermore, multivariable regression analysis showed that HA was independently associated with ARDS diagnosis (OR\u00a0=\u00a01.04, P\u00a0=\u00a00.007), severe ARDS (OR\u00a0=\u00a01.00, P &amp;lt; 0.001), and intubation risk (OR\u00a0=\u00a01.00, P\u00a0=\u00a00.011).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Plasma HA was positively associated with ARDS severity and intubation risk in patients with COVID-19. HA may serve as a complementary biomarker for early risk stratification, particularly when used in combination with established clinical severity scores.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1762512","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:25:48Z","timestamp":1776317148000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A nomogram for predicting ARDS progression and need for invasive ventilation in COVID-19 patients using plasma hyaluronic acid and clinical scores"],"prefix":"10.3389","volume":"16","author":[{"given":"Genhua","family":"Mu","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University","place":["Nanjing, Jiangsu, China"]},{"name":"Department of Critical Care Medicine, Yancheng No.1 People\u2019s Hospital, the Affiliated Hospital of the Medical School, Nanjing University","place":["Yancheng, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Renmin Hospital of Wuhan University","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Yancheng No.1 People\u2019s Hospital, the Affiliated Hospital of the Medical School, Nanjing University","place":["Yancheng, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Hou","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Yancheng No. 1 People\u2019s Hospital, the Affiliated Hospital of the Medical School, Nanjing University","place":["Yancheng, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songping","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Renmin Hospital of Wuhan University","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University","place":["Nanjing, Jiangsu, China"]},{"name":"Department of Critical Care Medicine, Sichuan Academy of Medical Sciences and Sichuan People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"C1037","DOI":"10.1152\/ajpcell.00071.2022","article-title":"The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19","volume":"322","author":"Albtoush","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jinf.2021.08.018","article-title":"Long-term impact of COVID-19 associated acute respiratory distress syndrome","volume":"83","author":"Aranda","year":"2021","journal-title":"J. Infect."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n436","article-title":"Severe covid-19 pneumonia: pathogenesis and clinical management","volume":"372","author":"Attaway","year":"2021","journal-title":"Bmj"},{"key":"B4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.matbio.2023.02.001","article-title":"Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection","volume":"116","author":"Barnes","year":"2023","journal-title":"Matrix Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12879-025-11045-8","article-title":"Evaluation of the performance of disease severity indices (SOFA, SAPS III, and MPM II) for the prediction of mortality rate in COVID-19 patients admitted to the intensive care units: a retrospective cross-sectional study","volume":"25","author":"Basiri","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.matbio.2018.06.006","article-title":"Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis","volume":"80","author":"Bell","year":"2019","journal-title":"Matrix Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"Jama"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1129766","article-title":"Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19","volume":"14","author":"Borrmann","year":"2023","journal-title":"Front. Immunol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-025-00169-9","article-title":"Organizing pneumonia in hospitalized COVID-19 patients: risk factors and long-term outcomes","volume":"17","author":"Cuerpo","year":"2025","journal-title":"Pneumonia (Nathan)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237471","article-title":"Diagnostic usefulness of serum hyaluronic acid in patients with SARS-CoV-2 infection","volume":"13","author":"Cylwik","year":"2024","journal-title":"J. Clin. Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02609-24","article-title":"Hyaluronan in COVID-19: a matrix for understanding lung disease","volume":"15","author":"Dodd","year":"2024","journal-title":"mBio"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1002\/cphy.c210029","article-title":"Endothelial glycocalyx","volume":"12","author":"Foote","year":"2022","journal-title":"Compr. Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"L785","DOI":"10.1152\/ajplung.00168.2015","article-title":"The role of hyaluronan in the pathobiology and treatment of respiratory disease","volume":"310","author":"Garantziotis","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"15418","DOI":"10.1074\/jbc.AC120.015967","article-title":"Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options","volume":"295","author":"Hellman","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01303-24","article-title":"SARS-CoV-2 infection induces hyaluronan production in vitro and hyaluronan levels in COVID-19 patients relate to morbidity and long-term lung impairment: a prospective cohort study","volume":"15","author":"Hellman","year":"2024","journal-title":"mBio"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103861","article-title":"SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network","volume":"76","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1338508","article-title":"Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era","volume":"14","author":"Li","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1406581","article-title":"Clinical and prognostic implications of hyaluronic acid in patients with COVID-19 reinfection and first infection","volume":"15","author":"Li","year":"2024","journal-title":"Front. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-025-02127-9","article-title":"Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies","volume":"10","author":"Ma","year":"2025","journal-title":"Signal. Transduct Target Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1164\/rccm.202303-0558WS","article-title":"A new global definition of acute respiratory distress syndrome","volume":"209","author":"Matthay","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2534849","article-title":"The predictive value of hyaluronic acid for the severity and prognosis of COVID-19: a retrospective multicenter cohort study","volume":"57","author":"Mu","year":"2025","journal-title":"Ann. Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.100795","article-title":"National incidence rate and related mortality for acute respiratory distress syndrome in France","volume":"40","author":"Papazian","year":"2021","journal-title":"Anaesth Crit. Care Pain Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/22221751.2021.1932607","article-title":"Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate","volume":"10","author":"Prieto-Fern\u00e1ndez","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147472","article-title":"COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction","volume":"6","author":"Queisser","year":"2021","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1382244","article-title":"The correlation between serum levels of laminin, type IV collagen, type III procollagen N-terminal peptide and hyaluronic acid with the progression of post-COVID-19 pulmonary fibrosis","volume":"12","author":"Yu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.139548","article-title":"Sepsis-associated endothelial glycocalyx damage: a review of animal models, clinical evidence, and molecular mechanisms","volume":"295","author":"Zhan","year":"2025","journal-title":"Int. J. Biol. Macromol"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1762512\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:25:49Z","timestamp":1776317149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1762512\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":26,"alternative-id":["10.3389\/fcimb.2026.1762512"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1762512","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1762512"}}